UPDATE : Monday, September 7, 2020
Amgen Korea wins new indication for acute lymphoblastic leukemia drug by Lee Han-soo 2020-09-04 18:04
SCM Lifescience punished for delaying adverse reaction report by Kim Chan-hyuk 2020-09-04 14:54
Iraq approves Hutox as 1st BTX product by Lee Han-soo 2020-09-04 14:16
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate by Kim Yun-mi 2020-09-03 14:50
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia by Shim Hyun-tai 2020-09-03 12:36
Daewoong to expand indication of Nabota in US by Lee Han-soo 2020-09-03 12:13
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’ by Kim Yun-mi 2020-09-02 16:33
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries by Shim Hyun-tai 2020-09-02 14:08
FDA grants priority review to Hanmi’s Oraxol by Lee Han-soo 2020-09-02 13:06
MedPacto’s oncology pipeline for blood cancer wins EU patent by Shim Hyun-tai 2020-09-01 17:14
AZ requests court to nullify Dong-A ST’s avoidance of Forxiga patent by Kim Yun-mi 2020-09-01 15:40
MSD’s antiviral Prevymis gains insurance coverage by Shim Hyun-tai 2020-09-01 15:05
LG Chem, SK Bioscience end sales partnership with Daewoong by Kim Chan-hyuk 2020-09-01 14:12
LSK Global PS to conduct P3 trial of Sinovac's Covid-19 vaccine candidate by Lee Han-soo 2020-09-01 12:17
Doctors force drug sales reps to support ongoing strike by Kim Yun-mi 2020-09-01 11:24
MSD Korea’s Keytruda wins 2 new indications for treating cancer by Shim Hyun-tai 2020-08-31 16:44
China gives nod to Huonland’s eye drop for allergic inflammation by Shim Hyun-tai 2020-08-31 15:28
‘Korea should introduce indication-specific drug pricing’ by Kim Yun-mi 2020-08-31 15:28
Collaboration: One way to simplify complexities in drug development by Lee Han-soo 2020-08-31 13:52
Takeda’s Alunbrig available as primary therapy for lung cancer by Shim Hyun-tai 2020-08-28 15:52
Back to Top